Register entry
Almirall, LLC
- Registered sites
- 0
- Drug products
- 11
- Live patents
- 21
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
21Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| ACZONE | DAPSONE | Nov 2033 |
| ALTABAX | RETAPAMULIN | Feb 2027 |
| KLISYRI | TIRBANIBULIN | Dec 2027 |
| KLISYRI | TIRBANIBULIN | Feb 2029 |
| KLISYRI | TIRBANIBULIN | Dec 2030 |
| KLISYRI | TIRBANIBULIN | Mar 2038 |
| KLISYRI | TIRBANIBULIN | Sept 2038 |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | Aug 2028 |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | Dec 2029 |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | Jan 2032 |
| SEYSARA | SARECYCLINE HYDROCHLORIDE | Feb 2033 |
Catalogue
Marketed products
11Showing 11 of 11.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| AZELEX | azelaic acid | CREAM | NDA |
| Aczone | dapsone | GEL | NDA |
| CORDRAN | flurandrenolide | TAPE | NDA |
| Klisyri | tirbanibulin | OINTMENT | NDA |
| Seysara | sarecycline hydrochloride | TABLET, COATED | NDA |
| Seysara | sarecycline hydrochloride | TABLET, COATED | NDA |
| Seysara | sarecycline hydrochloride | TABLET, COATED | NDA |
| TAZORAC | tazarotene | CREAM | NDA |
| TAZORAC | tazarotene | CREAM | NDA |
| Tazorac | tazarotene | GEL | NDA |
| Tazorac | tazarotene | GEL | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.